198 related articles for article (PubMed ID: 27650729)
1. Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.
Shimshoni JA; Winkler I; Golan E; Nutt D
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):15-24. PubMed ID: 27650729
[TBL] [Abstract][Full Text] [Related]
2. Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum.
Fuwa T; Suzuki J; Tanaka T; Inomata A; Honda Y; Kodama T
J Toxicol Sci; 2016; 41(3):329-37. PubMed ID: 27193726
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
4. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
5. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
[TBL] [Abstract][Full Text] [Related]
6. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
[TBL] [Abstract][Full Text] [Related]
7. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
8. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
Johnson MP; Conarty PF; Nichols DE
Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Tada Y; Inomata A
J Appl Toxicol; 2017 Mar; 37(3):243-252. PubMed ID: 27291301
[TBL] [Abstract][Full Text] [Related]
10. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by phthalide analogues.
Strydom B; Bergh JJ; Petzer JP
Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869
[TBL] [Abstract][Full Text] [Related]
12. The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat.
Dawson P; Opacka-Juffry J; Moffatt JD; Daniju Y; Dutta N; Ramsey J; Davidson C
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():57-63. PubMed ID: 24012617
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical profiles of some novel psychoactive substances.
Iversen L; Gibbons S; Treble R; Setola V; Huang XP; Roth BL
Eur J Pharmacol; 2013 Jan; 700(1-3):147-51. PubMed ID: 23261499
[TBL] [Abstract][Full Text] [Related]
14. Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
Steuer AE; Boxler MI; Stock L; Kraemer T
Toxicol Lett; 2016 Jan; 243():48-55. PubMed ID: 26721607
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of novel psychoactive benzofurans.
Rickli A; Kopf S; Hoener MC; Liechti ME
Br J Pharmacol; 2015 Jul; 172(13):3412-25. PubMed ID: 25765500
[TBL] [Abstract][Full Text] [Related]
16. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
17. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
Montgomery T; Buon C; Eibauer S; Guiry PJ; Keenan AK; McBean GJ
Br J Pharmacol; 2007 Dec; 152(7):1121-30. PubMed ID: 17891159
[TBL] [Abstract][Full Text] [Related]
18. Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters.
Sandtner W; Stockner T; Hasenhuetl PS; Partilla JS; Seddik A; Zhang YW; Cao J; Holy M; Steinkellner T; Rudnick G; Baumann MH; Ecker GF; Newman AH; Sitte HH
Mol Pharmacol; 2016 Jan; 89(1):165-75. PubMed ID: 26519222
[TBL] [Abstract][Full Text] [Related]
19. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME
J Psychopharmacol; 2019 Jul; 33(7):831-841. PubMed ID: 31038382
[TBL] [Abstract][Full Text] [Related]
20. Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.
Bauer CT; Banks ML; Blough BE; Negus SS
Psychopharmacology (Berl); 2015 Sep; 232(17):3249-58. PubMed ID: 26041338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
